Tianhong Li welcomes LGBT patients.
Dr. Li has been involved in several translational research projects since her fellowship training, leading to the publication of several original research papers. Areas of her current studies are in optimizing anti-epidermal growth receptor (EGFR) therapy in non-small cell lung cancer and combining charge farnesyl transferase inhibitor tipifarnib with cytotoxic and hormonal agents in breast cancer. She has served as principle investigator of several investigator-initiated studies in breast cancer and lung cancer.
As a physician-scientist, her main research focus is on understanding the mechanisms of action of novel targeted agents and developing rational therapeutic strategies for breast and lung cancer.
Co-Director, Phase I Program
2279 45th Street
Sacramento, CA 95817
Ph.D., Loyola University, Stritch School of Medicine, Maywood , Illinois, 1996
American Board of Internal Medicine, Hematology and Oncology, 2013
American Society of Clinical Oncology
American Society of Hematology
Breast Evaluation Center, Montefiore Medical Center/Albert Eintstein Cancer Center
Chinese American Hematologist/Oncologist Network
Eastern Cooperative Oncology Group
Experimental Therapeutic Program at the UC Davis Cancer Center
International Association for the Study of Lung Cancer
NCI/Cancer Therapy Evaluation Program
Select Honors and Awards:
Mentor for Third Prize, 2008 Annual Young Investigator Award, Montefiore Medical Center, Bronx, NY, 2008
Third Prize, Eleventh Annual Young Investigator Award, Montefiore Medical Center, Bronx, NY, 2007
Third Prize, Ninth Annual Young Investigators Symposium, Montefiore Medical Center, Bronx, NY, 2005
Fellowship, Second Accelerating Anticancer Agent Development and Validation Workshop, Sponsored by: Duke Comprehensive Cancer Center, American Association for Cancer Research, American Society of Clinical Oncology, National Cancer Institute, NIH, and U.S. Food and Drug Administration (FDA), North Bethesda, Maryland, 2005
Fellowship, Second National Medical Oncology Fellows’ Forum, 2003
Fellowship, Fifty FECS (Federation of European Cancer Societies)-AACR (American Association for Cancer Research)-ASCO (American Society of Clinical Oncology) Workshop on “Methods in Clinical Cancer Research”, Flims, Switzerland, 2003
Fellowship, First NCI-Sponsored OncoTalk Retreat (Teaching Communication Skills with Patients to Medical Oncology Fellows), Aspen, Colorado, 2002
ECOG-Aventis Young Investigator, ECOG Annual Meeting, 2002
Graduated top 5% of class (a size of over 200 students), Beijing Medical University, 1989
Award for Outstanding Research Accomplishment, Beijing Medical University, 1988
Select Recent Publications:
For a comprehensive list of Dr. Li's publications, please click here (opens new window).